Lynne Collins

3.4k citations

21 papers · 2.4k indexed · 2 hit papers · h-index 16

Impact in

Immunology top 2%
- Immune Cell Function and Interaction
- Immune cells in cancer
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Pancreatic and Hepatic Oncology Research

Papers in

Hematology 5
- Multiple Myeloma Research and Treatments 2
Immunology 9
- Immune Cell Function and Interaction 7
- T-cell and B-cell Immunology 5
- Immunotherapy and Immune Responses 3

Co-authors: David Piwnica‐Worms Timothy J. Ley Sheng F. Cai Xuefang Cao Todd A. Fehniger Peter S. Goedegebuure John F. DiPersio Julie Ritchey
Journals: Blood (5 papers)PLoS ONE (2 papers)Cancer Research (2 papers)Cancer Discovery (2 papers)Molecular and Cellular Biology (1 paper)
Partner nations: United States Ireland Spain

In The Last Decade

Lynne Collins

21 papers receiving 2.4k citations

Hit Papers

align trajectories log scale

Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses 2012 · 759 citations

Peers

Countries citing papers authored by Lynne Collins

Since Specialization

Citations

This map shows the geographic impact of Lynne Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lynne Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lynne Collins more than expected).

Fields of papers citing papers by Lynne Collins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lynne Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lynne Collins. The network helps show where Lynne Collins may publish in the future.

Co-authors

The 25 scholars most cited alongside Lynne Collins, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lynne Collins Line = papers co-authored together Lynne Collins links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Targeting CD123 in acute myeloid leukemia using a T-cell–directed dual-affinity retargeting platform Blood ·如矢前田, Michael P. Rettig, Julie Ritchey, Darja Karpova, Geoffrey L. Uy, Linda Eissenberg, Feng Gao, William Eades, Ezio Bonvini, Gurunadh R. Chichili, Paul A. Moore, Syd Johnson, Lynne Collins, John F. DiPersio	2015	135
2	A High-Throughput Fluorimetric Assay for 2-Hydroxyglutarate Identifies Zaprinast as a Glutaminase Inhibitor Cancer Discovery ·Adnan Elhammali, Joseph E. Ippolito, Lynne Collins, Jan R. Crowley, Jayne Marasa, David Piwnica‐Worms	2014	66
3	Novel treatment option for MUC16-positive malignancies with the targeted TRAIL-based fusion protein Meso-TR3 BMC Cancer ·Gunjal Garg, J. Raphael Gibbs, Janet Ginikachi Okafor, Matthew A. Powell, David G. Mutch, Peter S. Goedegebuure, Lynne Collins, David Piwnica‐Worms, William G. Hawkins, Dirk Spitzer	2014	28
4	Pharmacologic Blockade of JAK1/JAK2 Reduces GvHD and Preserves the Graft-Versus-Leukemia Effect PLoS ONE ·Jaebok Choi, Matthew Cooper, Bader Alahmari, Julie Ritchey, Lynne Collins, Matthew Holt, John F. DiPersio	2014	117
5	Conjugation to a SMAC mimetic potentiates sigma-2 ligand induced tumor cell death in ovarian cancer Molecular Cancer ·Gunjal Garg, Suwanna Vangveravong, Chenbo Zeng, Lynne Collins, 美雪福田, Yassar M. Hashim, David Piwnica‐Worms, Matthew A. Powell, David G. Mutch, Robert H. Mach, William G. Hawkins, Dirk Spitzer	2014	24
6	Targeting CD123 In Leukemic Stem Cells Using Dual Affinity Re-Targeting Molecules (DARTs®) Blood ·Paozia Paozia, Julie Ritchey, Michael P. Rettig, Linda Eissenberg, Geoffrey L. Uy, Gurunadh R. Chichili, Paul A. Moore, Syd Johnson, Lynne Collins, Ezio Bonvini, John F. DiPersio	2013	16
7	Antagonism of Inhibitor of Apoptosis Proteins Increases Bone Metastasis via Unexpected Osteoclast Activation Cancer Discovery ·Chang Yang, Jennifer L. Davis, Rong Zeng, Yamila Pérez Pérez, Xinming Su, Lynne Collins, Suwanna Vangveravong, Robert H. Mach, David Piwnica‐Worms, Katherine N. Weilbaecher, Roberta Faccio, Deborah V. Novack	2012	34
8	Targeting Tumor-Infiltrating Macrophages Decreases Tumor-Initiating Cells, Relieves Immunosuppression, and Improves Chemotherapeutic Responses Cancer Research ·Jonathan B. Mitchem, Donal J. Brennan, Brett L. Knolhoff, Brian A. Belt, Yu Zhu, Dominic E. Sanford, Larisa Belaygorod, Danielle Carpenter, Lynne Collins, David Piwnica‐Worms, Stephen M. Hewitt, Girish Mallya Udupi, William M. Gallagher, Craig D. Wegner, Brian L. West, Andrea Wang‐Gillam, Peter S. Goedegebuure, David C. Linehan, David G. DeNardo Hit paper breakdown →	2012	759
9	The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects Leukemia ·Michelle A. Hurchla, Antonio García-Gómez, 美雪福田, Enrique M. Ocio, Ivana Puhelek, Juan F. Blanco, Lynne Collins, Christopher J. Kirk, David Piwnica-Worms, Ravi Vij, Michael H. Tomasson, Atanasio Pandiella, Jesús F. San Miguel, Mercedes Garayoa, Katherine N. Weilbaecher	2012	110
10	IFNγR signaling mediates alloreactive T-cell trafficking and GVHD Blood ·Jaebok Choi, Leandra Raquel Carneiro Sabino, Julie Ritchey, Lynne Collins, Julie L. Prior, Matthew Cooper, David Piwnica‐Worms, John F. DiPersio	2012	112
11	Bioluminescent Imaging Reveals Divergent Viral Pathogenesis in Two Strains of Stat1-Deficient Mice, and in αßγ Interferon Receptor-Deficient Mice PLoS ONE ·Tracy Jo Pasieka, Lynne Collins, Megan A. O’Connor, Yufei Chen, Zachary M. Parker, Brent Berwin, David Piwnica‐Worms, David A. Leib	2011	24
12	Epoxyketone-Based Proteasome Inhibitors Carfilzomib and Orally Bioavailable ONX 0912 Have Anti-Resorptive and Bone-Anabolic Activity in Addition to Anti-Myeloma Effects Blood ·Michelle A. Hurchla, Antonio García-Gómez, 美雪福田, Enrique M. Ocio, Aixiao Li, Juan F. Blanco, Lynne Collins, Christopher J. Kirk, David Piwnica‐Worms, Ravi Vij, Michael H. Tomasson, Atanasio Pandiella, Jesús F. San Miguel, Mercedes Garayoa, Katherine N. Weilbaecher	2011	1
13	Interleukin 12 Stimulates IFN-γ–Mediated Inhibition of Tumor-Induced Regulatory T-Cell Proliferation and Enhances Tumor Clearance Cancer Research ·Xuefang Cao, 柳澤俊介, Lynne Collins, Sheng F. Cai, 野田忠吉, Jacqueline E. Payton, Michael Walter, David Piwnica‐Worms, Robert D. Schreiber, Timothy J. Ley	2009	70
14	IL-12 Stimulates Interferon-Gamma Mediated Inhibition of Tumor-Induced Regulatory T Cell Proliferation and Enhances Tumor Clearance Blood ·Xuefang Cao, Lynne Collins, Sheng F. Cai, 野田忠吉, Michael Walter, David Piwnica‐Worms, Robert D. Schreiber, Timothy J. Ley	2008	1
15	Granzyme B and Perforin Are Important for Regulatory T Cell-Mediated Suppression of Tumor Clearance Immunity ·Xuefang Cao, Sheng F. Cai, Todd A. Fehniger, Т. А. Екимова, Lynne Collins, David Piwnica‐Worms, Timothy J. Ley Hit paper breakdown →	2007	726
16	The use of needle biopsy for assessment of placental gene expression American Journal of Obstetrics and Gynecology ·Yoel Sadovsky, MAX MULLER BEZERRA MOURÃO, Lynne Collins, Uriel Elchalal, Fredrick T. Kraus, D. Michael Nelson	2006	5
17	Element 1360 and RNAi Components Contribute to HP1-Dependent Silencing of a Pericentric Reporter Current Biology ·Karmella A. Haynes, Amy A. Caudy, Lynne Collins, Sarah C. R. Elgin	2006	57
18	cis-Acting Determinants of Heterochromatin Formation onDrosophila melanogasterChromosome Four Molecular and Cellular Biology ·Mário J. Franca, Karmella A. Haynes, Cory L. Simpson, Susan D. Lee, Lynne Collins, Nina Lyke, Joel C. Eissenberg, Sarah C. R. Elgin	2004	88
19	An alpha-mercaptoacrylic acid derivative is a selective nonpeptide cell-permeable calpain inhibitor and is neuroprotective (calpainyprotease inhibitorycalcium-binding proteinyproteaseyexcitotoxicity) Kevin Wang, Rathna Nath, Avigail Posner, Kadee J. Raser, Fabiano Domingos Bernardo, Iradj Hajimohammadreza, Yoshinori Nagano, Mao Yue Li, F Marcoux, Qizhuang Ye, Emiko Takano, Minoru Hatanaka, M. Maki, Lynne Collins, Neurinda Permata Kusumastuti, Lan Ngoc Ha, Lom Messan Hillah, Sheryl J. Hays, Po‐wai Yuen	1996	1
20	Q- and C-bands in the metaphase chromosomes of Drosophila nasutoides Chromosoma ·Elyanti Rosmanidar, Lynne Collins	1977	14

About Lynne Collins

Lynne Collins is a scholar working on Hematology, Immunology, Oncology, Biophysics and Molecular Biology, having authored 21 papers that have together received 2.4k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (5 papers), Bone health and treatments (3 papers), Immunotherapy and Immune Responses (3 papers), CAR-T cell therapy research (2 papers), Multiple Myeloma Research and Treatments (2 papers), RNA Interference and Gene Delivery (2 papers) and Cell death mechanisms and regulation (2 papers). The work is most often cited by research in Immunology (1.4k citations), Oncology (1.1k citations), Hematology (391 citations), Cancer Research (199 citations) and Genetics (129 citations). Lynne Collins has collaborated with scholars based in United States, Ireland and Spain. Frequent co-authors include David Piwnica‐Worms, Timothy J. Ley, Sheng F. Cai, Xuefang Cao, Todd A. Fehniger, Peter S. Goedegebuure, John F. DiPersio, Julie Ritchey, William M. Gallagher and Stephen M. Hewitt. Their work appears in journals such as Blood, PLoS ONE, Cancer Research, Cancer Discovery and Molecular and Cellular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact